Opioids is a type of medicine used to relieve pain as it lowers the number of pain signals which body sends to the brain. It is often prescribed by the doctors to relive pain from toothaches and dental procedures, surgeries, injuries and chronic disease. Opioids have both, benefits if taken for right condition and when used properly, however when taken in excess, it develops into a serious risk leading to mortality in patients. According to US FDA, many people in US have been impacted by serious harm associated with these medications and hence to reduce the impact of opioid misuse and abuse, US FDA has developed a comprehensive Opioids Action Plan so as to address the growing epidemic of opioid abuse and dependence and overdose.
Global opioids market is segmented based of drug class, therapeutic application, and regions. Factors driving demand for opioid market includes increasing prevalence of chronic disease globally and rising number of product approvals in various region which will further augment the market growth over the forecast period. However, stringent government regulation regarding the prescription of the opioids so to avoid the dependency and misuse of these drug will limit the growth of global opioids market over the forecast period.
Do Inquiry About Report Here: https://marketresearch.biz/report/opioids-market/#inquiry
The application segment includes pain management, diarrhea treatment, and cough treatment. Pain management segment is expected to contribute major market share in opioids drug market, owing to the increasing prescription of opioids drugs in chronic diseases such as cancer, orthopedic etc. Revenue from the market in Asia Pacific is expected to continue to rise significantly into the future owing to factors such as increasing prevalence of chronic disease in the region.
Some prominent players in the global opioids market are Pfizer Inc., Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi S.A., Allergan, Plc, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd., Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, and Endo Pharmaceuticals Inc.